Bioengineering Research Partnerships (U01 Clinical Trial Required)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) encourages bioengineering applications that will accelerate the development and adoption of promising tools and technologies that can address important biomedical problems.  The objectives are to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need and are capable of enhancing our understanding of life science processes or the practice of medicine.  Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies, and engage biomedical researchers or clinicians throughout the project.  The goal of the program is to support projects that can realize meaningful solutions within 5 – 10 years.   

Companion FOA:   PAR-19-156, Clinical Trial Not Allowed

Deadlines:

  • U01 Due Date(s): Feb. 5, Jun. 5, Oct. 5
  • AIDS Application Due Date(s): Jan. 7, May 7, Sep. 7

PAR-19-157 Expiration Date January 8, 2022

Eligibility

Faculty

Category

Engineering and Physical Sciences
Environmental & Life Sciences
Interdisciplinary
Medical
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

October 5, 2021